33 min listen
Frequently Asked Questions About CMV Management
Frequently Asked Questions About CMV Management
ratings:
Length:
11 minutes
Released:
Nov 6, 2023
Format:
Podcast episode
Description
In this episode, Atul Humar, MD, FRCP(C); Hannah Imlay, MD, MS; and Raymund Razonable, MD, discuss cytomegalovirus (CMV) management strategies in solid organ transplantation recipients, including:Evaluation of current data on CMV prevention in liver transplant recipientsPractical considerations for switching an institution’s antiviral therapy of choice for primary prophylaxisBarrier of resistance to antiviral therapiesFactors to consider when deciding CMV treatment durationUse of lymphocyte count to assess CMV cell–mediated immunityProgram Director:Atul Humar, MD, FRCP(C)Professor of MedicineUniversity of Toronto Director, Ajmera Transplant CentreUniversity Health NetworkR. Fraser Elliott Chair in TransplantationDirector University of Toronto Transplant InstituteToronto, Ontario, CanadaFaculty:Hannah Imlay, MD, MSAssistant Professor of MedicineDepartment of Internal Medicine, Division of Infectious DiseasesUniversity of Utah Salt Lake City, UtahRaymund Razonable, MDProfessor of MedicineProgram Director, Infectious Diseases FellowshipVice Chair, Division of Infectious DiseasesMayo ClinicRochester, Minnesota Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program: https://bit.ly/47lNK2K
Released:
Nov 6, 2023
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 5: In Part 5 of this ongoing 12-part COVID-19 series, listen to a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission, followed by answers to critical clinician questions on COVID-19 transmission and mitigation by David Heymann, BA, MD, DTM&H. by CCO Infectious Disease Podcast